Target intelligence / Profile preview

Octopamine receptor in mushroom bodies (OAMB) (OAMB)

Target
OAMB
Molecular classification
G protein-coupled receptor, Biogenic amine receptor, Adrenergic-like receptor
01

Overview

The Varroa destructor Octopamine receptor in mushroom bodies (OAMB) is a G protein-coupled receptor (GPCR) that serves as a vital mediator of octopaminergic signaling in the parasitic mite Varroa destructor (UniProt: A0A0P0V6G1). Octopamine is the primary biogenic amine in invertebrates, functioning similarly to norepinephrine in vertebrates to regulate arousal, locomotion, and reproduction (Blenau et al., 2020, Journal of Insect Physiology). In Varroa mites, OAMB is specifically linked to the regulation of ovulation and the coordination of complex behaviors necessary for parasitizing honey bees (Apis mellifera). As a therapeutic target, OAMB is of high interest for the development of acaricides because octopamine receptors are not found in vertebrates, offering a window for selective toxicity (Gross et al., 2017, Pesticide Biochemistry and Physiology). However, the high degree of homology between Varroa OAMB and the honey bee's own OAMB receptor poses a significant challenge for achieving species-specific control without harming the host (Blenau et al., 2020). Existing acaricides like Amitraz are known to interact with octopamine receptors, and research into OAMB-specific ligands continues to be a priority in managing mite resistance.

Other names
VdOAMBOctopamine receptor alpha-1-likeOctopamine receptor type 1Varroa destructor octopamine receptorOctopamine receptor in mushroom bodies
02

Mechanism of action

Agonist or antagonist binding to the octopamine receptor disrupts downstream G protein signaling (typically Gq or Gs), leading to physiological impairment, reproductive failure, or paralysis in the parasite.

03

Biological functions

Signal transductionOvulationLocomotionLearning and memoryReproductive behavior
04

Disease associations

Parasitic infestationVarroosis
05

Safety considerations

Selectivity against host (Apis mellifera) octopamine receptorsDevelopment of acaricide resistanceEnvironmental persistence and toxicity to non-target invertebrates
06

Interacting drugs

Amitraz

6 more in the full profile.

07

Biomarkers

Mite mortality rateMite reproductive successMite locomotor activity

Beyond the preview

Go deeper on Octopamine receptor in mushroom bodies (OAMB) (OAMB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Octopamine receptor in mushroom bodies (OAMB) (OAMB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call